RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
TFA Therapeutics, Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$9.18+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
14 of TFA Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 6-K | Sep 2, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 25, 2026 | Jun 25, 2026 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2025 | May 15, 2026 | SEC EDGAR |
| Current report | 6-K | Nov 25, 2025 | Nov 26, 2025 | SEC EDGAR |
| Annual report, amended | 20-F/A | Dec 31, 2023 | Sep 23, 2025 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2024 | Jun 13, 2025 | SEC EDGAR |
| Current report | 6-K | Dec 6, 2024 | Dec 6, 2024 | SEC EDGAR |
| Annual report, amended | 20-F/A | Dec 31, 2023 | Oct 28, 2024 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2023 | Jul 5, 2024 | SEC EDGAR |
| Current report | 6-K | Mar 18, 2024 | Mar 19, 2024 | SEC EDGAR |
| Current report | 6-K | Sep 30, 2023 | Nov 13, 2023 | SEC EDGAR |
| Current report | 6-K | Sep 28, 2023 | Sep 28, 2023 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2022 | May 15, 2023 | SEC EDGAR |